LAKE OSWEGO, Ore., Feb. 7, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate update at the 14th Annual BIO CEO & Investor Conference. The presentation will take place on Monday, February 13th, 2012 at 2:30 PM EST at the Waldorf Astoria Hotel, New York, NY.
